V. Videm et al., Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo, J THOR SURG, 117(4), 1999, pp. 803-809
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: Our objective was to study mechanisms for reduced complement act
ivation by heparin coating of cardiopulmonary bypass equipment in clinical
heart surgery, Methods: Adults undergoing elective coronary artery bypass g
rafting were randomized to cardiopulmonary bypass with Duraflo II heparin-c
oated (n = 15) or uncoated (n = 14) sets (Duraflo coating surface; Baxter I
nternational, Inc, Deerfield, Ill), Blood samples were analyzed with the us
e of enzyme immunoassays for C1rs-C1 inhibitor complexes and the activation
products Bb, C4bc, C3bc, C5a-desArg, and the terminal complement complex.
Data were compared by repeated-measures analysis of variance. Results: C1 w
as activated during bypass, and increases in C1rs-C1 inhibitor complexes we
re larger with heparin coating (P = .03). C4bc increased after administrati
on of protamine, without intergroup differences (P = .69). Bb (P = .22) and
C5a-desArg (P = .13) tended to increase less with heparin coating. Formati
on of C3bc (P = .03) and the terminal complement complex (P < .01) was sign
ificantly reduced with heparin coating. C5a-desArg increased 2-fold during
bypass, whereas the terminal complement complex increased 10- to 20-fold, M
aximal terminal complement complex concentrations were significantly correl
ated to maximal Bb and C3bc (R = 0.6, P < .001), but not to C1rs-C1 inhibit
or complexes or C4bc (R < 0.05, P > .8). Conclusions: C1 activation during
bypass was increased by heparin coating, but further classical pathway acti
vation was held in check until administration of protamine, Heparin coating
significantly inhibited C3bc and terminal complement complex formation. Te
rminal complement complex concentrations were related to alternative pathwa
y activation and may be useful for evaluation of differences in bypass circ
uitry. Increases and intergroup differences in terminal complement complex
concentrations were much larger than those in C5a-desArg.